ZimVie’s (ZIMV) Hold Rating Reiterated at Needham & Company LLC

by · The Cerbat Gem

Needham & Company LLC reissued their hold rating on shares of ZimVie (NASDAQ:ZIMV – Free Report) in a research report released on Thursday morning, Benzinga reports.

Several other brokerages also recently commented on ZIMV. Barclays boosted their target price on ZimVie from $13.00 to $16.00 and gave the stock an underweight rating in a report on Tuesday, March 5th. JPMorgan Chase & Co. boosted their target price on ZimVie from $10.00 to $16.00 and gave the stock a neutral rating in a report on Wednesday, December 20th.

Get Our Latest Report on ZIMV

ZimVie Stock Down 6.1 %

NASDAQ ZIMV opened at $15.90 on Thursday. The company has a current ratio of 2.78, a quick ratio of 2.32 and a debt-to-equity ratio of 1.26. The stock’s 50 day moving average is $17.78 and its two-hundred day moving average is $14.12. The company has a market capitalization of $432.81 million, a price-to-earnings ratio of -1.07 and a beta of 2.18. ZimVie has a 1-year low of $6.52 and a 1-year high of $20.91.

ZimVie (NASDAQ:ZIMV – Get Free Report) last released its quarterly earnings data on Wednesday, February 28th. The company reported $0.10 earnings per share for the quarter. The company had revenue of $113.07 million for the quarter. ZimVie had a positive return on equity of 2.44% and a negative net margin of 51.33%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of ZIMV. Scarborough Advisors LLC acquired a new position in ZimVie during the 4th quarter worth $28,000. Tower Research Capital LLC TRC lifted its holdings in ZimVie by 388.7% during the 3rd quarter. Tower Research Capital LLC TRC now owns 3,245 shares of the company’s stock worth $31,000 after buying an additional 2,581 shares in the last quarter. Natixis acquired a new position in ZimVie during the 4th quarter worth $35,000. US Bancorp DE lifted its holdings in ZimVie by 276.6% during the 4th quarter. US Bancorp DE now owns 2,806 shares of the company’s stock worth $50,000 after buying an additional 2,061 shares in the last quarter. Finally, Royal Bank of Canada lifted its holdings in ZimVie by 44.0% during the 2nd quarter. Royal Bank of Canada now owns 4,681 shares of the company’s stock worth $52,000 after buying an additional 1,430 shares in the last quarter. Institutional investors and hedge funds own 95.63% of the company’s stock.

ZimVie Company Profile

(Get Free Report)

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

Featured Articles